Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Prostatic Neoplasms 5Breast Neoplasms 4Ovarian Neoplasms 3Triple Negative Breast Neoplasms 2Polycystic Ovary Syndrome 2Pancreatic Neoplasms 2Overweight 2Obesity 2Multiple Myeloma 2Motor Activity 2Melanoma 2Lung Neoplasms 2Glioblastoma 2Colorectal Neoplasms 2Weight Loss 1Uveal Melanoma 1Smoking Cessation 1Quality of Life 1Postoperative Complications 1Patient Compliance 1Neoplasms 1Metabolic Syndrome 1Localized Prostate Carcinoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Insulin Resistance 1Inflammation 1Hypothalamic Neoplasms 1Healthy Diet 1Glioma 1Gastrointestinal Neoplasms 1

Interventions

pembrolizumab 88Carboplatin 77Specimen Handling 76Magnetic Resonance Spectroscopy 63Pemetrexed 59Cisplatin 47durvalumab 44Paclitaxel 38Nivolumab 34atezolizumab 32osimertinib 29Radiotherapy 29Radiosurgery 29Biopsy 26Blood Specimen Collection 25Gemcitabine 24Docetaxel 24Immunoglobulin G 23Disulfides 22Standard of Care 21Drug Therapy 21Etoposide 19Taxes 18Practice Guidelines as Topic 18Radiation 17Educational Status 16130-nm albumin-bound paclitaxel 15X-Rays 14Surveys and Questionnaires 14Bevacizumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lung Neoplasms × Diet Therapy × 1 year × Clear all
NCT03654105 2026-03-27

SMILE

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Active not recruiting
2,000 enrolled
Thoracic

Inflammation, Lung Neoplasms, Motor Activity, Smoking Cessation

NCT07042724 2025-06-29

STARLighT

Universita di Verona

Phase NA Recruiting
324 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡